Systematic review with meta-analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases.
Yang H, Li B, Guo Q, Tang J, Peng B, Ding N, Li M, Yang Q, Huang Z, Diao N, Zhu X, Deng J, Guo H, Hu P, Chao K, Gao X.
Yang H, et al. Among authors: huang z.
Aliment Pharmacol Ther. 2022 Apr;55(7):764-777. doi: 10.1111/apt.16802. Epub 2022 Feb 9.
Aliment Pharmacol Ther. 2022.
PMID: 35141914